Free product worth Rs 499 on all myUpchar products
Pexopram 0.125 Tablet is a prescription medicine that is available as a Tablet. Parkinson's Disease are some of its major therapeutic uses. Secondary and off-label uses of Pexopram 0.125 Tablet have also been mentioned below.
The optimal dosage of Pexopram 0.125 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Pexopram 0.125 Tablet as well, which are listed below. Such side effects of Pexopram 0.125 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Pexopram 0.125 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Pexopram 0.125 Tablet related warnings talks about Pexopram 0.125 Tablet's effects on the liver, heart and kidney.
Pexopram 0.125 Tablet is contraindicated in people with pre-existing medical conditions like Schizophrenia, Heart Disease, Kidney Disease as it can result in adverse effects.
Drug reaction of Pexopram 0.125 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Pexopram 0.125 Tablet is not safe while driving, and is not addiction.
Pexopram 0.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Pexopram 0.125 Tablet safe for pregnant women?
Pexopram can have harmful effects in pregnant women. If you experience any discomfort after using Pexopram, then discontinue the use and take your doctor's advice.
Is the use of Pexopram 0.125 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pexopram. So it is adviced to consult the doctor before using it.
What is the effect of Pexopram 0.125 Tablet on the Kidneys?
Pexopram has very mild side effects on the kidneys.
What is the effect of Pexopram 0.125 Tablet on the Liver?
Pexopram does not damage the liver.
What is the effect of Pexopram 0.125 Tablet on the Heart?
Very few cases of side effects of Pexopram on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Pexopram 0.125 Tablet unless your doctor advises you to do so -
Is this Pexopram 0.125 Tablet habit forming or addictive?
No, you will not get addicted to Pexopram 0.125 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Pexopram 0.125 Tablet. So it is best to avoid driving.
Is it safe?
Pexopram 0.125 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Pexopram 0.125 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Pexopram 0.125 Tablet
Pexopram 0.125 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Pexopram 0.125 Tablet
Consuming Pexopram 0.125 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
